Evidence map›Paper›PMID 37732317›Full record

ArticleFrontiers in genetics2023

Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension.

Gufeng Gao, Ai Chen, Jin Gong, Weijun Lin, Weibin Wu, Sagor Mohammad Ismail Hajary, Guili Lian, Li Luo, Liangdi Xie

Abstract read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gufeng GaoDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Ai ChenDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Jin GongDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Weijun LinDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Weibin WuDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Sagor Mohammad Ismail HajaryDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Guili LianDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Li LuoDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
Liangdi XieDepartment of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening disease with a poor prognosis and high heritability, characterized by elevated pulmonary vascular resistance (PVR) and pulmonary artery pressure. N6-methyladenosine (m6A) RNA modification influences many RNA metabolism pathways. However, the position of m6A methylation regulators in IPAH remains unknown. Therefore, the study aims to disclose the function m6A regulators exert in the pathological mechanisms of IPAH and the immune microenvironment involved. The GSE117261 dataset was downloaded from the Gene Expression Omnibus (GEO) to screen the differentially expressed genes (DEGs) between normal and IPAH samples. Functional and pathway enrichment analyses of DEGs were then conducted by Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG). We also identified the differentially-expressed m6A (DEm6A) regulators between normal and IPAH samples. Key m6A regulators related to the prediction of IPAH were selected using the random forest model. The results showed that FMR1, RBM15, HNRNPA2B1 and IGFBP3 were upregulated in IPAH. In contrast, LRPPRC was downregulated. The single sample gene set enrichment analysis (ssGSEA) method was then adopted to estimate the immune microenvironment in distinct m6A clusters and m6A phenotype-related genes (PRGs) clusters, respectively. Furthermore, we calculated the m6A score via principal component analysis (PCA), and the Sankey diagram was selected to present the correlation among the m6A clusters, m6A PRGs clusters and m6A score. Finally, quantitative RT-PCR and Western blotting were used to validate the key genes in human pulmonary artery smooth muscle cells (HPASMCs) treated by human platelet-derived growth factor-BB (PDGF-BB). The relative mRNA and protein expression levels of FMR1 were significantly elevated, however, the relative mRNA and protein expression levels of LRPPRC were downregulated. Besides, the relative mRNA level of HNRNPA2B1 was increased. Generally, this bioinformatics analysis might provoke more insights into diagnosing and treating IPAH.

Indexed as

human pulmonary artery smooth muscle cellsidiopathic pulmonary arterial hypertensionimmune microenvironmentm6A methylation regulatorsplatelet-derived growth factor-BB

Identifiers

PMID37732317
PMCPMC10507408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.